va-Q-tec reports record quarter in all corporate areas; very strong growth momentum accelerates
DGAP-News: va-Q-tec AG
/ Key word(s): Quarterly / Interim Statement
va-Q-tec reports record quarter in all corporate areas; very strong growth momentum accelerates - Revenue growth of +27% in Q1 2021 to EUR 22.4 million - Growth in all divisions: Products business +50%; Systems business +42%; Services +9% - Q1 2021 EBITDA up 63% to EUR 4.6 million; EBITDA margin improves significantly to 21% of revenues (previous year: 16%); EBIT clearly positive at EUR 1.4 million in Q1 2021 (previous year: EUR -0.2 million) - Continued high share of revenues in the healthcare sector at 72%: va-Q-tec thermal containers essential for temperature-controlled transport of CoVid-19 vaccines - Record quarter in all areas marks successful start to a promising financial year - FY 2021 forecast confirmed: revenues between EUR 90 - 100 million with a targeted further year-on-year increase in EBITDA margin
For the individual divisions of va-Q-tec AG, the trend was as follows overall: the Products business (sale of vacuum insulation panels) continued the performance from the second half of 2020. Thanks to rising demand for energy-efficient refrigerators and freezers in consumer markets, combined with the stay-at-home trend and the introduction of the new energy efficiency label for household appliances, revenues in this segment jumped 50% to EUR 6.3 million (previous year: EUR 4.2 million), the highest level ever achieved in this segment. In the Systems division (sale of thermal packaging), revenues were up by 42% year-on-year, from EUR 4.8 million to EUR 6.8 million, which also represents a record level. Business with the va-Q-pal SI (SI for SuperInsulation), a solution for transporting coronavirus vaccines to harder-to-reach regions of the world, performed particularly well. Likewise, a new product based on the va-Q-tray technology was developed within a very short period of time for the temperature-stable storage and transportation of filled vaccine syringes within vaccination centers. The Services business (rental of containers and boxes for the shipment of temperature-sensitive goods) also recorded a 9% increase in revenue in Q1 2021 to a reach a new quarterly record level of EUR 8.9 million (previous year: EUR 8.2 million). Here, va-Q-tec benefited above all from strong growth in the number of rentals of small thermal boxes for the "last mile", especially for vaccine distribution. Here, in particular, the company identifies further growth over the coming quarters thanks to vaccine shipments. The positive trend continued in the second quarter. For example, the increased availability of CoVid-19 vaccines both in Germany and worldwide is currently leading to greater demand for temperature-controlled transport solutions. va-Q-tec's thermal boxes and containers are being deployed extensively along the entire value chain - from the transportation of raw materials, and all the way through to vaccination centers. With possible booster vaccinations and adjustments of the vaccine to address virus mutations, this business could stabilize in subsequent years, and accelerate growth in the long term. However, it was not only in the area of TempChain logistics that business performed very well in Q1 2021: va-Q-tec's high-tech vacuum insulation panels offer crucial advantages, especially wherever secure and highly efficient insulation solutions are required in the tightest of spaces. Accordingly, va-Q-tec is not only valued as a reliable partner in the healthcare industry, but also in numerous other areas, such as the industrial insulation of pipelines, building insulation, and the high-tech insulation of electric vehicles. This is underscored, for example, by the strategic partnerships with Hutchinson for thermal management in the mobility sector, and with Uponor in the area of highly energy-efficient and form-flexible pipe insulation. In addition to the currently dominant TempChain business, va-Q-tec's innovative high-tech insulation solutions have put the company in an excellent position to benefit from the megatrend of climate protection through thermal energy efficiency. Dr. Joachim Kuhn, CEO of va-Q-tec AG, comments: "The bulk of the international vaccine roll-out is still in the start-up phase at present, so it is yet to come. We are proud that our temperature-stable and energy-efficient transport solutions are in use worldwide for the distribution of Covid-19 vaccines. This confirms the leading position of our products and solutions for temperature-stable transport. It is also pleasing to note that we are also seeing growing demand for our products outside the healthcare sector. This opens up further opportunities for us in the future. We have a clear vision to develop va-Q-tec into the leading high-performance company in the area of thermal energy efficiency and high-performance thermal packaging for TempChain logistics. And we see ourselves continuing on a very good path toward that goal in our twentieth anniversary year." +++END+++ IR contact cometis AG About va-Q-tec Further information: www.va-Q-tec.com
11.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | va-Q-tec AG |
Alfred-Nobel-Straße 33 | |
97080 Würzburg | |
Germany | |
Phone: | +49 (0)931 35 942 0 |
Fax: | +49 (0)931 35 942 10 |
E-mail: | IR@va-Q-tec.com |
Internet: | www.va-Q-tec.com |
ISIN: | DE0006636681 |
WKN: | 663668 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1194859 |
End of News | DGAP News Service |
|
1194859 11.05.2021